Katie Howell is a highly qualified infectious disease research scientist in the BioHealth Capital region of Gaithersburg, Maryland. She is currently using her scientific expertise and experience to build an antibody discovery company, with research interests focusing on vaccines and therapeutics for select agents such as Ebola, Marburg, Lassa, MERS-CoV, SARS-CoV, and COVID-19.

Katie is passionate about infectious disease research and has an impressive academic background. She studied biochemistry at Temple University, completing her degree with distinction in the major. She then earned a Doctor of Philosophy (Ph.D.) in Microbiology and Immunology at the University of Maryland Baltimore, where she went on to work as a graduate research assistant, teaching assistant, and Office of Science and Technology Policy Intern (OSTP) in the Executive Office of the President of the United States.

Katie has worked at various scientific organizations, including EliteImmune, Corp., Integrated BioTherapeutics, Inc., and the University of Maryland Office of Research and Development. She is a former Science Communication Intern at the University of Maryland School of Medicine and Office of Public Affairs and a former Technology Transfer Intern at the University of Maryland Office of Research and Development. She has received several awards and recognitions for her research, including the Summer Undergraduate Research Fellowship at Drexel University College of Medicine and Undergraduate Research at ALS Hope Foundation.

In conclusion, Katie Howell is a prominent infectious disease research scientist with a strong academic background and several years of experience in the field. Her research interests include vaccines and therapeutics for select agents, and she has worked at various scientific organizations. With her exceptional skills and expertise, she is undoubtedly an asset to the scientific community.